Annual EBITDA
-$10.27 M
+$13.83 M+57.37%
December 31, 2023
Summary
- As of February 7, 2025, ENSC annual EBITDA is -$10.27 million, with the most recent change of +$13.83 million (+57.37%) on December 31, 2023.
- During the last 3 years, ENSC annual EBITDA has fallen by -$11.11 million (-1330.51%).
- ENSC annual EBITDA is now -1330.51% below its all-time high of $834.80 thousand, reached on December 31, 2020.
Performance
ENSC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$665.80 K
+$2.61 M+134.32%
September 30, 2024
Summary
- As of February 7, 2025, ENSC quarterly EBITDA is $665.80 thousand, with the most recent change of +$2.61 million (+134.32%) on September 30, 2024.
- Over the past year, ENSC quarterly EBITDA has increased by +$3.83 million (+121.07%).
- ENSC quarterly EBITDA is now -62.31% below its all-time high of $1.77 million, reached on September 30, 2020.
Performance
ENSC Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$6.30 M
+$3.35 M+34.70%
September 30, 2024
Summary
- As of February 7, 2025, ENSC TTM EBITDA is -$6.30 million, with the most recent change of +$3.35 million (+34.70%) on September 30, 2024.
- Over the past year, ENSC TTM EBITDA has increased by +$3.97 million (+38.65%).
- ENSC TTM EBITDA is now -512.39% below its all-time high of $1.53 million, reached on December 31, 2020.
Performance
ENSC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ENSC EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +57.4% | +121.1% | +38.6% |
| 3 y3 years | -1330.5% | +121.1% | +38.6% |
| 5 y5 years | -1330.5% | +121.1% | +38.6% |
ENSC EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +63.1% | at high | +106.6% | at high | +82.5% |
| 5 y | 5-year | -1330.5% | +63.1% | -62.3% | +103.9% | -512.4% | +82.5% |
| alltime | all time | -1330.5% | +63.1% | -62.3% | +103.9% | -512.4% | +82.5% |
Ensysce Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $665.80 K(-134.3%) | -$6.30 M(-34.7%) |
| Jun 2024 | - | -$1.94 M(+3.8%) | -$9.65 M(-3.0%) |
| Mar 2024 | - | -$1.87 M(-40.9%) | -$9.95 M(-3.1%) |
| Dec 2023 | -$10.27 M(-57.4%) | -$3.16 M(+17.8%) | -$10.27 M(-18.1%) |
| Sep 2023 | - | -$2.68 M(+19.8%) | -$12.54 M(-36.4%) |
| Jun 2023 | - | -$2.24 M(+2.2%) | -$19.71 M(-22.3%) |
| Mar 2023 | - | -$2.19 M(-59.6%) | -$25.35 M(+5.2%) |
| Dec 2022 | -$24.10 M | -$5.43 M(-44.9%) | -$24.10 M(-16.0%) |
| Sep 2022 | - | -$9.85 M(+24.9%) | -$28.70 M(-20.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$7.89 M(+742.5%) | -$36.02 M(+27.8%) |
| Mar 2022 | - | -$935.90 K(-90.7%) | -$28.18 M(+1.3%) |
| Dec 2021 | -$27.85 M(-3436.2%) | -$10.02 M(-41.6%) | -$27.81 M(+58.7%) |
| Sep 2021 | - | -$17.17 M(>+9900.0%) | -$17.52 M(-1331.9%) |
| Jun 2021 | - | -$47.20 K(-91.6%) | $1.42 M(+47.4%) |
| Mar 2021 | - | -$563.80 K(-311.6%) | $964.50 K(-36.9%) |
| Dec 2020 | $834.80 K | $266.40 K(-84.9%) | $1.53 M(+21.1%) |
| Sep 2020 | - | $1.77 M(-450.0%) | $1.26 M(-350.0%) |
| Jun 2020 | - | -$504.80 K | -$504.80 K |
FAQ
- What is Ensysce Biosciences annual EBITDA?
- What is the all time high annual EBITDA for Ensysce Biosciences?
- What is Ensysce Biosciences annual EBITDA year-on-year change?
- What is Ensysce Biosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Ensysce Biosciences?
- What is Ensysce Biosciences quarterly EBITDA year-on-year change?
- What is Ensysce Biosciences TTM EBITDA?
- What is the all time high TTM EBITDA for Ensysce Biosciences?
- What is Ensysce Biosciences TTM EBITDA year-on-year change?
What is Ensysce Biosciences annual EBITDA?
The current annual EBITDA of ENSC is -$10.27 M
What is the all time high annual EBITDA for Ensysce Biosciences?
Ensysce Biosciences all-time high annual EBITDA is $834.80 K
What is Ensysce Biosciences annual EBITDA year-on-year change?
Over the past year, ENSC annual EBITDA has changed by +$13.83 M (+57.37%)
What is Ensysce Biosciences quarterly EBITDA?
The current quarterly EBITDA of ENSC is $665.80 K
What is the all time high quarterly EBITDA for Ensysce Biosciences?
Ensysce Biosciences all-time high quarterly EBITDA is $1.77 M
What is Ensysce Biosciences quarterly EBITDA year-on-year change?
Over the past year, ENSC quarterly EBITDA has changed by +$3.83 M (+121.07%)
What is Ensysce Biosciences TTM EBITDA?
The current TTM EBITDA of ENSC is -$6.30 M
What is the all time high TTM EBITDA for Ensysce Biosciences?
Ensysce Biosciences all-time high TTM EBITDA is $1.53 M
What is Ensysce Biosciences TTM EBITDA year-on-year change?
Over the past year, ENSC TTM EBITDA has changed by +$3.97 M (+38.65%)